Percutaneous Coronary Intervention for Chronic Stable Angina. A Reassessment

David Holmes, Bernard J. Gersh, Patrick Whitlow, Spencer B. King, James T. Dove

Research output: Contribution to journalReview article

30 Citations (Scopus)

Abstract

As it approaches its fourth decade, percutaneous coronary intervention (PCI) is now the most widely used revascularization strategy around the world and has been tested in multiple clinical scenarios against both medical and surgical therapies. For each patient group and clinical scenario setting, the goals of therapy must be specifically defined and clearly understood as an integral component of the process of selecting the optimal strategy for the individual patient. In patients with chronic stable, often mild angina, the major achievable goals of PCI are to affect symptoms, either by decreasing them or preventing them, reduce the need for subsequent procedures, and relieve ischemia. Achievement of these goals has been documented in multiple randomized trials of PCI versus medical therapy. In these trials of patients with stable coronary artery disease (CAD), however, no reduction in death and myocardial infarction has been observed, and these limitations of PCI in this clinical setting need to be emphasized. Given the typically diffuse nature of CAD and the fact that PCI only treats a segment within a coronary artery, this is not surprising. Although optimal medical therapy forms the cornerstone of management for any patient with CAD, among stable patients who do fail medical therapy, percutaneous coronary revascularization plays a well-documented significant role in improving symptoms and preventing the subsequent need for revascularization. The appropriate utilization rates of PCI in patients with chronic stable angina and preserved left ventricular function should lead to more cost-effective care of patients with stable CAD.

Original languageEnglish (US)
Pages (from-to)34-43
Number of pages10
JournalJACC: Cardiovascular Interventions
Volume1
Issue number1
DOIs
StatePublished - Feb 1 2008

Fingerprint

Stable Angina
Percutaneous Coronary Intervention
Coronary Artery Disease
Therapeutics
Left Ventricular Function
Coronary Vessels
Patient Care
Ischemia
Myocardial Infarction
Costs and Cost Analysis

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Percutaneous Coronary Intervention for Chronic Stable Angina. A Reassessment. / Holmes, David; Gersh, Bernard J.; Whitlow, Patrick; King, Spencer B.; Dove, James T.

In: JACC: Cardiovascular Interventions, Vol. 1, No. 1, 01.02.2008, p. 34-43.

Research output: Contribution to journalReview article

Holmes, David ; Gersh, Bernard J. ; Whitlow, Patrick ; King, Spencer B. ; Dove, James T. / Percutaneous Coronary Intervention for Chronic Stable Angina. A Reassessment. In: JACC: Cardiovascular Interventions. 2008 ; Vol. 1, No. 1. pp. 34-43.
@article{2b93b90c24f44382b815b2a2f8e64238,
title = "Percutaneous Coronary Intervention for Chronic Stable Angina. A Reassessment",
abstract = "As it approaches its fourth decade, percutaneous coronary intervention (PCI) is now the most widely used revascularization strategy around the world and has been tested in multiple clinical scenarios against both medical and surgical therapies. For each patient group and clinical scenario setting, the goals of therapy must be specifically defined and clearly understood as an integral component of the process of selecting the optimal strategy for the individual patient. In patients with chronic stable, often mild angina, the major achievable goals of PCI are to affect symptoms, either by decreasing them or preventing them, reduce the need for subsequent procedures, and relieve ischemia. Achievement of these goals has been documented in multiple randomized trials of PCI versus medical therapy. In these trials of patients with stable coronary artery disease (CAD), however, no reduction in death and myocardial infarction has been observed, and these limitations of PCI in this clinical setting need to be emphasized. Given the typically diffuse nature of CAD and the fact that PCI only treats a segment within a coronary artery, this is not surprising. Although optimal medical therapy forms the cornerstone of management for any patient with CAD, among stable patients who do fail medical therapy, percutaneous coronary revascularization plays a well-documented significant role in improving symptoms and preventing the subsequent need for revascularization. The appropriate utilization rates of PCI in patients with chronic stable angina and preserved left ventricular function should lead to more cost-effective care of patients with stable CAD.",
author = "David Holmes and Gersh, {Bernard J.} and Patrick Whitlow and King, {Spencer B.} and Dove, {James T.}",
year = "2008",
month = "2",
day = "1",
doi = "10.1016/j.jcin.2007.10.001",
language = "English (US)",
volume = "1",
pages = "34--43",
journal = "JACC: Cardiovascular Interventions",
issn = "1936-8798",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Percutaneous Coronary Intervention for Chronic Stable Angina. A Reassessment

AU - Holmes, David

AU - Gersh, Bernard J.

AU - Whitlow, Patrick

AU - King, Spencer B.

AU - Dove, James T.

PY - 2008/2/1

Y1 - 2008/2/1

N2 - As it approaches its fourth decade, percutaneous coronary intervention (PCI) is now the most widely used revascularization strategy around the world and has been tested in multiple clinical scenarios against both medical and surgical therapies. For each patient group and clinical scenario setting, the goals of therapy must be specifically defined and clearly understood as an integral component of the process of selecting the optimal strategy for the individual patient. In patients with chronic stable, often mild angina, the major achievable goals of PCI are to affect symptoms, either by decreasing them or preventing them, reduce the need for subsequent procedures, and relieve ischemia. Achievement of these goals has been documented in multiple randomized trials of PCI versus medical therapy. In these trials of patients with stable coronary artery disease (CAD), however, no reduction in death and myocardial infarction has been observed, and these limitations of PCI in this clinical setting need to be emphasized. Given the typically diffuse nature of CAD and the fact that PCI only treats a segment within a coronary artery, this is not surprising. Although optimal medical therapy forms the cornerstone of management for any patient with CAD, among stable patients who do fail medical therapy, percutaneous coronary revascularization plays a well-documented significant role in improving symptoms and preventing the subsequent need for revascularization. The appropriate utilization rates of PCI in patients with chronic stable angina and preserved left ventricular function should lead to more cost-effective care of patients with stable CAD.

AB - As it approaches its fourth decade, percutaneous coronary intervention (PCI) is now the most widely used revascularization strategy around the world and has been tested in multiple clinical scenarios against both medical and surgical therapies. For each patient group and clinical scenario setting, the goals of therapy must be specifically defined and clearly understood as an integral component of the process of selecting the optimal strategy for the individual patient. In patients with chronic stable, often mild angina, the major achievable goals of PCI are to affect symptoms, either by decreasing them or preventing them, reduce the need for subsequent procedures, and relieve ischemia. Achievement of these goals has been documented in multiple randomized trials of PCI versus medical therapy. In these trials of patients with stable coronary artery disease (CAD), however, no reduction in death and myocardial infarction has been observed, and these limitations of PCI in this clinical setting need to be emphasized. Given the typically diffuse nature of CAD and the fact that PCI only treats a segment within a coronary artery, this is not surprising. Although optimal medical therapy forms the cornerstone of management for any patient with CAD, among stable patients who do fail medical therapy, percutaneous coronary revascularization plays a well-documented significant role in improving symptoms and preventing the subsequent need for revascularization. The appropriate utilization rates of PCI in patients with chronic stable angina and preserved left ventricular function should lead to more cost-effective care of patients with stable CAD.

UR - http://www.scopus.com/inward/record.url?scp=41349095071&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=41349095071&partnerID=8YFLogxK

U2 - 10.1016/j.jcin.2007.10.001

DO - 10.1016/j.jcin.2007.10.001

M3 - Review article

C2 - 19393142

AN - SCOPUS:41349095071

VL - 1

SP - 34

EP - 43

JO - JACC: Cardiovascular Interventions

JF - JACC: Cardiovascular Interventions

SN - 1936-8798

IS - 1

ER -